Human umbilical cord mesenchymal stem cell-derived exosomes promote osteogenesis in glucocorticoid-induced osteoporosis through PI3K/AKT signaling pathway-mediated ferroptosis inhibition
Stem Cells Translational Medicine · 18.03.2025 · 14 (3)
DOI: 10.1093/stcltm/szae096 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cells Translational Medicine, online erschienen am 21.04.2025. Verfasst von Zhi-Meng Zhao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Shandong Provincial Hospital, Shandong University, Jinan, Shandong 250021, People's Republic of China. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Osteogenesis, Exosomes, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Glucocorticoid-induced osteoporosis (GIOP), the most common cause of secondary osteoporosis, is characterized by significant bone loss, decreased bone quality, and increased fracture risk. The current treatments for GIOP have several drawbacks. Exosomes are vital for cellular processes. However, very few studies have focused on using human umbilical cord mesenchymal stem cell-derived exosomes (hUCMSC-EXOs) for GIOP treatment. In vitro and in vivo dexamethasone was used to evaluate the therapeutic effects of hUCMSC-EXOs on GIOP. CCK-8 and EdU assays were used to evaluate cell viability and proliferation, respectively. We conducted an alkaline phosphatase activity assay, alizarin red staining, Western blotting, and real-time PCR to detect the effect on osteogenesis. TMT-labeled quantitative proteomic and bioinformatic analyses were performed. Furthermore, we performed Western blotting, immunofluorescence, reactive oxygen species assays, and lipid peroxidation assays to investigate the regulatory mechanism by which hUCMSC-EXOs affect cell proliferation and osteogenic differentiation. The in vivo effects of hUCMSC-EXOs were evaluated using micro-CT, hematoxylin, and eosin staining, and immunohistochemical staining. We found that hUCMSC-EXOs reversed the inhibitory effects of glucocorticoids on human bone marrow stromal cell (hBMSC) proliferation and osteogenic differentiation and demonstrated that hUCMSC-EXOs reversed GIOP via the PI3K/AKT signaling pathway, inhibiting lipid peroxidation in vitro and in vivo. HUCMSC-EXOs promote hBMSC osteogenesis through the PI3K/AKT signaling pathway, inhibit ferroptosis, and have therapeutic potential for GIOP in mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, Shandong Provincial Hospital, Shandong University, Jinan, Shandong 250021, People's Republic of China.
- Department of Orthopedics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, People's Republic of China.
- Department of Spine Surgery, The Second Hospital of Shandong University, Jinan, Shandong 250033, People's Republic of China.
ORCID-Profile: Da-Chuan Wang
Förderung
- Natural Science Foundation of Shandong Province
Zitieren
APA
Zhao, Z. M., Ding, J. M., Li, Y., Wang, D. C., & Kuang, M. J. (2025). Human umbilical cord mesenchymal stem cell-derived exosomes promote osteogenesis in glucocorticoid-induced osteoporosis through PI3K/AKT signaling pathway-mediated ferroptosis inhibition. Stem Cells Translational Medicine, 14(3). https://doi.org/10.1093/stcltm/szae096
Vancouver
Zhao ZM, Ding JM, Li Y, Wang DC, Kuang MJ. Human umbilical cord mesenchymal stem cell-derived exosomes promote osteogenesis in glucocorticoid-induced osteoporosis through PI3K/AKT signaling pathway-mediated ferroptosis inhibition. Stem Cells Translational Medicine. 2025;14(3). doi:10.1093/stcltm/szae096
BibTeX
@article{Zhao2025,
author = {Zhao, Zhi-Meng and Ding, Jia-Ming and Li, Yu and Wang, Da-Chuan and Kuang, Ming-Jie},
title = {Human umbilical cord mesenchymal stem cell-derived exosomes promote osteogenesis in glucocorticoid-induced osteoporosis through PI3K/AKT signaling pathway-mediated ferroptosis inhibition},
journal = {Stem Cells Translational Medicine},
year = {2025},
volume = {14},
number = {3},
doi = {10.1093/stcltm/szae096}
}
EUVIMED